Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

PARAINFLUENZA VIRUS - ANVISA Registration 80213250552

Access comprehensive regulatory information for PARAINFLUENZA VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80213250552 and manufactured by R-BIOPHARMA AG. The registration is held by PHAREBEE DIAGNOSTICOS COMERCIO IMPORTACAO E EXPORTACAO DE PRODUTOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARMA AG, REMEL INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80213250552
Registration Details
ANVISA Registration Number: 80213250552
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Ridascreen Parainfluenza 1, 2, 3 IgG
Risk Class II

Registration Details

80213250552

25351045152201482

64128853000196

Company Information

R-BIOPHARMA AG
Germany
PT: ALEMANHA

Dates and Status

Mar 31, 2014

VIGENTE

09/18/2025 19:00:01